Torrent Pharmaceuticals promoter is likely to sell a 2.9% stake worth Rs 3,000 crore via block deal on Wednesday. The offer price is likely...

India sales that constitute 57% of Torrent's revenues grew 15% YoY to Rs 1,635 crores in Q1FY25 led by outperformance in focus therapies.

Consolidated net profit was 3.86 billion rupees ($46.4 million) for the quarter ended Sept. 30, compared with 3.12 billion rupees a year ea...

Revenues rose 7% YoY to Rs 2,291 crore during Q2FY23

Revenues rose 7% YoY to Rs 2,291 crore during Q2FY23, compared to Rs 2,137 crore in Q2FY22.

Torrent Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Export Incentives for the y...

Consolidated revenue from operations of the company stood at Rs 2,134 crore for the quarter under consideration. It was Rs 2,056 crore for ...

Torrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 43659.46 Crore) operating in...

The company had posted a net loss of Rs 152 crore for the corresponding period of the previous financial year.

Buy Torrent Pharmaceuticals Ltd. at a price target of Rs 1570 and that target can be reached in a year.

Torrent Pharma is significantly ramping up in US with ~100 filings targeted over next 3 years

A strong growth in Brazil has offset sluggish growth recorded in India, the global investment bank said

Torrent Pharma said it has commenced production from its new plant in Gujarat, the first phase of which has come up at an investment of ove...

The company reported a net profit of Rs 167 crore, up 6 per cent, from a net profit of Rs 158 crore, in the corresponding quarter last fisc...

Torrent Pharmaceuticals Ltd, Q2 registered 7% revenue de-growth in Brazil, consolidated Q2 net profit grew by 7% and revenue by 13%.

The company had posted a consolidated net profit of Rs 76.91 crore for the quarter ended December 31, 2010, Torrent Pharmaceuticals said in...

The company's Brazil sales increased to Rs 102 crore for the third quarter, compared to Rs 89 crore in the same period last fiscal.